Endocrine Abstracts

149 haemodialysis chronic renal failure (CRF) patients on haemodialysis (HD) program of 4 h/three times a week investigated for thyroid gland function and try to answer the question: is the thyroid function abnormality affect the response of the haemodialysis CRF patients response to recombinant human erythropoietin (rHuEPO)? We compare the results of the thyroid gland markers; T₃, T₄, and TSH (which tested by minividus technique) of the patients with the packet cell volume (PCV) values of the patients and showed if the haemodialysis CRF with hyper or hypothyroidism affect the response of the patients to the rHuEPO and if there are differences in the values of the PCV between the groups of the patients after fixed the duration and the times of the HD session and the same dose and route of the rHuEPO. The results analysed statistically and discussed and from that we can concluded there are hyporesponsiveness of the rHuEPO in patients with CRF and hypothyroidism in haemodialysis and for this reason we advise to search any haemodialysis patients for thyroid function.